The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitor use on ketonemia, blood pressure, and renal function in Muslim patients with type 2 diabetes
Shao Y et al. Diabetes Res Clin Prac 2018. doi: 10.1016/j.diabres.2018.05.022
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.